Literature DB >> 25578290

24 h Levodopa-carbidopa intestinal gel may reduce falls and "unresponsive" freezing of gait in Parkinson's disease.

Florence C F Chang1, David S Tsui1, Neil Mahant1, Nigel Wolfe1, Samuel D Kim1, Ainhi D Ha1, Melissa Drury1, Jane M Griffith1, Victor S C Fung2.   

Abstract

OBJECTIVE: We report a prospective, open label study of 24 h levodopa-carbidopa intestinal gel (LCIG) as treatment for levodopa "unresponsive" freezing of gait (FOG) associated with Parkinson's disease.
METHOD: 5 patients with disabling FOG, documented as being levodopa "unresponsive", were commenced on continuous 24 h infusion LCIG therapy with the night-time rate at 50-80% of the daytime infusion rate. Patients underwent baseline, 3 and 6 month gait assessments, documentation of their falls frequency and completed FOG questionnaires. RESULT: Median 360° turn time improved by 54%, fall frequency score reduced from 3 to 0 at 6 months, FOG questionnaire score improved by 14% and Timed Up- and -Go 8 m walk was unchanged.
CONCLUSION: 24 h LCIG therapy may reduce levodopa "unresponsive" FOG and associated falls. A larger prospective study is needed for confirmation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbidopa–levodopa intestinal gel; Freezing of gait; Parkinson's disease

Mesh:

Substances:

Year:  2014        PMID: 25578290     DOI: 10.1016/j.parkreldis.2014.12.019

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  16 in total

Review 1.  Managing Gait, Balance, and Posture in Parkinson's Disease.

Authors:  Bettina Debû; Clecio De Oliveira Godeiro; Jarbas Correa Lino; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-06       Impact factor: 5.081

2.  Levodopa-carbidopa intrajejunal gel in advanced Parkinson disease with "on" freezing of gait.

Authors:  Giovanni Cossu; Valeria Ricchi; Manuela Pilleri; Francesca Mancini; Daniela Murgia; Gianluigi Ricchieri; Alessandra Mereu; Maurizio Melis; Angelo Antonini
Journal:  Neurol Sci       Date:  2015-05-05       Impact factor: 3.307

Review 3.  Freezing of gait: overview on etiology, treatment, and future directions.

Authors:  Marika Falla; Giovanni Cossu; Alessio Di Fonzo
Journal:  Neurol Sci       Date:  2022-01-14       Impact factor: 3.307

Review 4.  Pharmacological treatment in Parkinson's disease: Effects on gait.

Authors:  Katrijn Smulders; Marian L Dale; Patricia Carlson-Kuhta; John G Nutt; Fay B Horak
Journal:  Parkinsonism Relat Disord       Date:  2016-07-17       Impact factor: 4.891

Review 5.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

6.  Levodopa/Carbidopa Intestinal Gel Infusion Therapy: Focus on Gait and Balance.

Authors:  Vittorio Rispoli; Nico Golfrè Andreasi; Giovanna Penna; Francesca Preda; Eleonora Contini; Mariachiara Sensi
Journal:  Mov Disord Clin Pract       Date:  2018-10-25

Review 7.  Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Authors:  Maria José Catalán; Angelo Antonini; Matilde Calopa; Ovidiu Băjenaru; Oriol de Fábregues; Adolfo Mínguez-Castellanos; Per Odin; José Manuel García-Moreno; Stephen W Pedersen; Zvezdan Pirtošek; Jaime Kulisevsky
Journal:  eNeurologicalSci       Date:  2017-07-02

Review 8.  Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments.

Authors:  Chao Gao; Jun Liu; Yuyan Tan; Shengdi Chen
Journal:  Transl Neurodegener       Date:  2020-04-15       Impact factor: 8.014

Review 9.  Freezing of Gait in Parkinsonism and its Potential Drug Treatment.

Authors:  Li-Li Zhang; S Duff Canning; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 10.  Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.

Authors:  Michelle Burack; Jason Aldred; Cindy Zadikoff; Arvydas Vanagunas; Kevin Klos; Bahri Bilir; Hubert H Fernandez; David G Standaert
Journal:  Mov Disord Clin Pract       Date:  2018-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.